ABOUT WORLD HEALTHEX FORUM
Pharma Leaders Forum Co-Host Partner
 

What is it?

HealthEx Pharma World is a high profile forum designed primarily for the larger and mid cap ( >$1bn) Pharma and Life Science company C-suite and board level executives, and key influential partners and stakeholders in the sector. For those leading the largest companies in healthcare.

This is a 40-person Chatham House Rule, formatted forum in which industry leaders discuss and shape the future of their sector behind closed doors. They are hollow-square formats and not your standard one-dimensional meeting format meaning all executives engage in meaningful strategic and sector debate and discussion. The forums will address the key industry challenges head on, providing genuine outcomes for the executives and the sector as a whole.

The 40 seats will be allocated with no fewer than 36 executives and KOLs, with the remaining seats taken by  Forum Co-Hosts that may include 1 Global Advisory, 1 Law Firm, 1 CRO and / or 1 Investor. The GEO breakdown will roughly be 40 US, 50% UK and EU and 10% RoW.

This is a 40-person Chatham House Rule, formatted forum in which industry leaders discuss and shape the future of their sector behind closed doors. They are hollow-square formats and not your standard one-dimensional meeting format meaning all executives engage in meaningful strategic and sector debate and discussion. The forums will address the key industry challenges head on, providing genuine outcomes for the executives and the sector as a whole.

WHO IS IT FOR?

CEO, CFOs, CBOs, Executives, Head of R&D, Head of BD&L of large and midcap (>$1bn) Pharma and Biotech. It is not for small cap or private pharma and biotech.

the case studies

CEOs and/or event partners put forward case studies – either success stories or current challenges - and use the group as “consultants”. Each case study follows this format:

Headline – short and enticing
Nutshell – a concise statement of the issue
Background – the players, the issue, what was at stake, etc
What Was Tried? - what worked and what didn’t
Questions - clarifying questions from the group.
Peer Consultation
Review - what are you taking back with you? what will you try?

the general discussion

All the attendees in the room will be asked: “If you could have the answer to one question, that would fundamentally help change the way your business runs, what would it be?"

The questions will be scored– the highest score going to the question asked by the most people, and that becoming the focus of the discussion. General notes:

  • Time will be managed carefully, with plenty of time for discussion
  • Each speaker will be asked to communicate a clear message & solicit specific feedback
  • The moderator will be briefed to guide the discussion to touch on all participants' concerns 

Executives can explore in this session: 

The Industry and Business Agenda
Focussing on creating value in an outcomes focused environment - developing robust policies for maximising revenues generated by specific drugs in the post-blockbuster era, cost management in new treatments in specialist market, flexibility in approach to mitigate risks in the global economy and its affect on the Pharma industry.

The R&D Agenda
Increasing internal innovation for new therapies for the world’s unmet medical needs, how get drugs to patients faster, ensuring the most effective business development, licensing and M&A strategies to expedite and monetise the latest external innovations

The Investment Agenda
Creating shareholder value as a >$1bn Pharma company

The Future Agenda
The changing role of large cap Pharma will grow and develop, the evolution of leadership, flexibility in approach to mitigate risks in the global economy



Are you interested in a seat at the table and would like to be considered for an invitation to attend the HealthEx Pharma World Forum?